AlphaXIV
AlphaXIV36About
What does AlphaXIV do?
AlphaXIV is a fitness and wellness platform offering challenges, programs, workouts, recovery, nutrition advice, and fitness tracking. It also provides tech, coaching, and motivation resources to help users achieve their fitness goals. The platform serves individuals interested in improving their physical health and performance.
What is AlphaXIV's valuation?
StartupHub estimates AlphaXIV's effective valuation at $25.0M (range $17.5M to $42.0M, 15% confidence), based on comparable companies in the sector.
How much funding has AlphaXIV raised?
AlphaXIV has raised a total of $7M in funding. The most recent round on record is Seed.
Where is AlphaXIV headquartered?
AlphaXIV is headquartered in San Francisco, United States.
When was AlphaXIV founded?
AlphaXIV was founded in 2023.
What industry does AlphaXIV operate in?
AlphaXIV operates in Generative AI, AI Tools & Apps, Content Creation, Marketing Automation, Creative Workflow Automation, Foundation Model.
FDFL is a South Florida consultancy that embeds operators inside SMB operations to ship one production AI-assisted workflow at a time.
Asib provides AI-powered tools for creative professionals to generate and manage visual content.
AI-powered platform for personalized premium content creation and distribution.
AI design review for schematics, finding issues with datasheet evidence before board orders.
AI-powered platform for personalized learning experiences and educational content creation.
A platform for discovering, saving, and sharing AI prompts and AI-generated images.
AI startup focused on agent readiness and overview.
AAIO is an AI All-in-One Toolbox curating and organizing AI solutions for productivity and growth.
An entrant is a company tagged AI Tools & Apps whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.